
Rabbit Anti-AKT1/3 Polyclonal Antibody #abs130566
Please note that the mentioned price is only for your reference. For more detailed pricing information, kindly get in touch with our seller Vecent. It is important to understand that the price may vary based on certain factors, and our seller will be the best person to provide you with a...
Description
Catalog-specification | Delivery time | USD price |
abs130566-50ug | 1-2 Weeks | 201 |
abs130566-100ug | 1-2 Weeks | 301 |
Please note that the mentioned price is only for your reference. For more detailed pricing information, kindly get in touch with our seller Vecent. It is important to understand that the price may vary based on certain factors, and our seller will be the best person to provide you with a specific quote. So, don't hesitate to contact Vecent for all your price-related queries.
Overview | |
Description | The AKT1 gene encodes a serine-threonine protein kinase that lacks catalytic activity when fibroblasts are serum-starved, whether they are primary or immortalized. Activation of AKT1 and its related isoform AKT2 occurs when stimulated by platelet-derived growth factor. This activation process is both rapid and specific, and mutations in the pleckstrin homology domain of AKT1 prevent this activation. Studies have demonstrated that phosphatidylinositol 3-kinase is responsible for mediating this activation. In the developing nervous system, AKT plays a crucial role as a mediator of growth factor-induced neuronal survival. By activating the serine/threonine kinase AKT1, survival factors can inhibit apoptosis in a transcription-independent manner. This occurs through phosphorylation and inactivation of components within the apoptotic machinery. Furthermore, numerous alternatively spliced transcript variants have been discovered for this gene. |
Other names | Akt, also known as protein kinase B, is a serine/threonine protein kinase that belongs to the AKT family of enzymes. There are three isoforms of Akt in humans: Akt1, Akt2, and Akt3. Akt1 and Akt2 are widely expressed in different tissues, while Akt3 has a more restricted expression pattern. Akt plays a crucial role in cell growth, survival, metabolism, and proliferation by phosphorylating a variety of downstream targets, including transcription factors, cell cycle regulators, and metabolic enzymes. Dysregulation of Akt signaling is implicated in numerous diseases, including cancer, diabetes, Alzheimer's disease, and cardiovascular disease. Therefore, Akt is an important target for therapeutic intervention. |
Source | Rabbit |
Specificity | The AKT1/3 Antibody has been developed to specifically detect the levels of AKT1/3 that naturally occur within an organism. By utilizing this antibody, researchers are able to accurately measure the presence of AKT1/3 and gain insight into their biological functions. The sensitivity of the antibody ensures reliable and precise results, making it a valuable tool in various research applications. |
Species Reactivity | Mouse;Rat;Human |
Application | WB 1:500-1:2000, ELISA(peptide) 1:20000-1:40000 |
Immunogen | A synthesized peptide derived from human AKT1/3 |
Properties | |
Concentration | 1mg/ml |
Purification | Immunogen affinity purified |
Clonality | Polyclonal Antibody |
Stability & Storage | To ensure optimal storage, please keep this item at a temperature of -20 °C for a period of one year. To avoid any damage, do not subject the product to repeated cycles of freezing and thawing. It is essential to adhere to these instructions to maintain the quality and effectiveness of this item. |
Storage buffer | The Rabbit IgG is stored in phosphate buffered saline with a pH of 7.4. It contains 150mM NaCl, 0.02% sodium azide, and 50% glycerol. It should be stored at -20 °C and has a shelf life of 12 months from the date of receipt. |
Target | |
Background | AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis. This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates. Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported. AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface. Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling. Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport. AKT regulates also the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity. Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven. AKT regulates also cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis. AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating mTORC1 signaling and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1. AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization. In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319'. FOXO3 and FOXO4 are phosphorylated on equivalent sites. AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1. AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis. Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis. Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI3P-5 activity. The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth. AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation. Signals downstream of phosphatidylinositol 3-kinase (PI3K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor I (IGF-I). AKT mediates the antiapoptotic effects of IGF-I. Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly. May be involved in the regulation of the placental development. Phosphorylates STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its: kinase activity, nuclear translocation, autophosphorylation and ability to phosphorylate FOXO3. Phosphorylates STK3/MST2 at 'Thr-117' and 'Thr-384' leading to inhibition of its: cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation. Phosphorylates SRPK2 and enhances its kinase activity towards SRSF2 and ACIN1 and promotes its nuclear translocation. Phosphorylates RAF1 at 'Ser-259' and negatively regulates its activity. Phosphorylation of BAD stimulates its pro-apoptotic activity. Phosphorylates KAT6A at 'Thr-369' and this phosphorylation inhibits the interaction of KAT6A with PML and negatively regulates its acetylation activity towards p53/TP53. |
Tissue specificity | Expressed in prostate cancer and levels increase from the normal to the malignant state (at protein level). Expressed in all human cell types so far analyzed. The Tyr-176 phosphorylated form shows a significant increase in expression in breast cancers during the progressive stages i.e. normal to hyperplasia (ADH), ductal carcinoma in situ (DCIS), invasive ductal carcinoma (IDC) and lymph node metastatic (LNMM) stages. |
Posttranslational modification | O-GlcNAcylation at Thr-305 and Thr-312 inhibits activating phosphorylation at Thr-308 via disrupting the interaction between AKT1 and PDPK1. O-GlcNAcylation at Ser-473 also probably interferes with phosphorylation at this site.Phosphorylation on Thr-308, Ser-473 and Tyr-474 is required for full activity. Activated TNK2 phosphorylates it on Tyr-176 resulting in its binding to the anionic plasma membrane phospholipid PA. This phosphorylated form localizes to the cell membrane, where it is targeted by PDPK1 and PDPK2 for further phosphorylations on Thr-308 and Ser-473 leading to its activation. Ser-473 phosphorylation by mTORC2 favors Thr-308 phosphorylation by PDPK1. Phosphorylated at Thr-308 and Ser-473 by IKBKE and TBK1. Ser-473 phosphorylation is enhanced by interaction with AGAP2 isoform 2 (PIKE-A). Ser-473 phosphorylation is enhanced in focal cortical dysplasias with Taylor-type balloon cells. Ser-473 phosphorylation is enhanced by signaling through activated FLT3. Dephosphorylated at Thr-308 and Ser-473 by PP2A phosphatase. The phosphorylated form of PPP2R5B is required for bridging AKT1 with PP2A phosphatase. Ser-473 is dephosphorylated by CPPED1, leading to termination of signaling.Ubiquitinated via 'Lys-48'-linked polyubiquitination by ZNRF1, leading to its degradation by the proteasome (By similarity). Ubiquitinated; undergoes both 'Lys-48'- and 'Lys-63'-linked polyubiquitination. TRAF6-induced 'Lys-63'-linked AKT1 ubiquitination is critical for phosphorylation and activation. When ubiquitinated, it translocates to the plasma membrane, where it becomes phosphorylated. When fully phosphorylated and translocated into the nucleus, undergoes 'Lys-48'-polyubiquitination catalyzed by TTC3, leading to its degradation by the proteasome. Also ubiquitinated by TRIM13 leading to its proteasomal degradation. Phosphorylated, undergoes 'Lys-48'-linked polyubiquitination preferentially at Lys-284 catalyzed by MUL1, leading to its proteasomal degradation.Acetylated on Lys-14 and Lys-20 by the histone acetyltransferases EP300 and KAT2B. Acetylation results in reduced phosphorylation and inhibition of activity. Deacetylated at Lys-14 and Lys-20 by SIRT1. SIRT1-mediated deacetylation relieves the inhibition. |
Celluar localization | Cytoskeleton;Cytosol;Mitochondrion;Nucleus;Plasma Membrane; |
UniPort | P31749/Q9Y243 |
Data Examples

Western blot analysis on K562 cell lysate using AKT1/3 Antibody
This product is for research use only, not for use in diagnostic prodecures or in human.
Hot Tags: rabbit anti-akt1/3 polyclonal antibody #abs130566, China rabbit anti-akt1/3 polyclonal antibody #abs130566 suppliers
Send Inquiry
You Might Also Like
-

Rabbit Anti-Gastrin Polyclonal Antibody #abs130444
-

Rabbit Anti-Fibrillin-1 Polyclonal Antibody #abs130335
-

Rabbit Anti-Histone H1.0 Polyclonal Antibody #abs130294
-

Rabbit Anti-TAF5L Polyclonal Antibody #abs130283
-

Phospho-Paxillin(Ser178) Rabbit Polyclonal Antibody ...
-

Rabbit Anti-CD11b/c Polyclonal Antibody #abs120423
